Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Key differences at a glance Understanding GLP-1 medications GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes but have revolutionised obesity treatment
If you stop taking GLP-1 medication for weight loss, the effects will wear off over several weeks
Neurotoxicology 92:166179
GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
Due to GPhC requirements, you cannot add the medication to your basket here
It depends
US$ 22.86
US$ 28.22
US$ 24.96
US$ 21.62
US$ 24.56
US$ 27.77
US$ 21.02
US$ 29.62
US$ 29.37
US$ 28.41
US$ 26.98
